GlassScriptPhysician profile
Shannon K Hoffman
NPI 1689910713
$8,339.98
in general payments reported to CMS, 2019-2025
55 companies · $2,160 in 2025
The $2,160 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,237 · 2022: $1,378 · 2023: $1,891 · 2024: $1,674 · 2025: $2,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,724.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,414.78 | 2021-2025 | |
| Novo Nordisk INC | $998.84 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $722.05 | 2021-2025 | |
| Lilly USA, LLC | $568.59 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $469.75 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $435.73 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $319.01 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $248.60 | 2021-2025 | Gardasil 9, Capvaxive, Belsomra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.53 | 2022-2025 | Jardiance |
| Astellas Pharma US INC | $228.66 | 2021-2025 | Veozah, Myrbetriq |
| Lundbeck LLC | $208.01 | 2022-2025 | Rexulti |
| Amgen INC. | $207.65 | 2021-2025 | Prolia, Evenity, Repatha |
| Novartis Pharmaceuticals Corporation | $206.67 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $147.64 | 2021-2023 | |
| Exact Sciences Corporation | $136.59 | 2023-2025 | Cologuard Collection Kit |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.